The growing burden of prostate cancer worldwide is accelerating the demand for innovative prostate cancer drugs, advanced oncology therapeutics, and emerging prostate cancer immunotherapy solutions. Prostate cancer remains one of the most commonly diagnosed cancers among men, with advanced cases often progressing into castrate-resistant prostate cancer (CRPC), a stage where...